Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
Loss of the <i>Adenomatous Polyposis Coli</i> (<i>APC</i>) tumor suppressor in colorectal cancer elicits rapid signaling through the Wnt/β-catenin signaling pathway. In contrast to this well-established role of APC, recent studies from our laboratory demonstrated tha...
Main Authors: | Jennifer M. Cole, Kaitlyn Simmons, Jenifer R. Prosperi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/9/1084 |
Similar Items
-
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
by: Aleksandra Adamska, et al.
Published: (2017-06-01) -
Adenomatous polyposis coli in cancer and therapeutic implications
by: Olivia Noe, et al.
Published: (2021-06-01) -
KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma
by: Xing Huang, et al.
Published: (2023-02-01) -
Characterization of Adenomatous Polyposis Coli Protein Dynamics and Localization at the Centrosome
by: Christina Lui, et al.
Published: (2016-04-01) -
Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study
by: A. Gueiderikh, et al.
Published: (2024-02-01)